Logo Logo
Switch Language to German
Kauffmann-Guerrero, D.; Kahnert, K.; Reu, S.; Jung, A.; Synyaeva, Z.; Mertsch, P.; Huber, R. M. (2017): NSCLC patients harbouring a rare or complex EGFR mutation are more often smokers and might not benefit from first line TKI therapy. In: Annals of Oncology, Vol. 28
Full text not available from 'Open Access LMU'.